Home › Funds › MPM BioImpact LLC › IMCR
MPM BioImpact LLC position in IMCR
IMMUNOCORE HLDGS PLC · Health Care
MPM BioImpact LLC reported holding 1,203,289 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$36.4M, representing 2.81% of its reported portfolio and ranking #13 among its reported holdings. MPM BioImpact LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's IMCR position evolved
MPM BioImpact LLC first disclosed a stake in IMCR in Q3 2026 at 1,203,289 shares (US$36.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.20M | $36.45M | New |
About IMCR and 13F data
IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 27 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$147.5M), TANG CAPITAL MANAGEMENT LLC (US$87.4M), Bellevue Group AG (US$68.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMCR
- RTW INVESTMENTS, LP 4.87M sh · $147.51M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 2.88M sh · $87.36M · Q3 2026
- Bellevue Group AG 2.26M sh · $68.59M · Q3 2026
- Caligan Partners LP 1.67M sh · $50.65M · Q3 2026
- Kynam Capital Management, LP 1.38M sh · $41.65M · Q3 2026
- BVF INC/IL 1.23M sh · $37.28M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.14M sh · $34.41M · Q3 2026
- Trails Edge Capital Partners, LP 1.06M sh · $32.21M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 928.00K sh · $28.11M · Q3 2026
- BRAIDWELL LP 906.12K sh · $27.45M · Q3 2026
- Vestal Point Capital, LP 850.00K sh · $25.75M · Q3 2026
- Frazier Life Sciences Management, L.P. 829.75K sh · $25.13M · Q3 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held IMCR?
MPM BioImpact LLC has disclosed IMCR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is MPM BioImpact LLC's current position in IMCR?
As of Q3 2026, MPM BioImpact LLC holds 1.20M shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $36.45M, representing 2.81% of its reported portfolio and ranking #13.
Has MPM BioImpact LLC been buying or selling IMCR?
In the latest 13F filing (Q3 2026), MPM BioImpact LLC newly opened its position in IMCR.
Which other funds hold IMCR?
Other major institutional holders of IMCR include RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, Bellevue Group AG, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.